Aethlon Med Inc.

13F holders, Q1 2026 (March 31)
12holders +4
6new positions
2sold out
$2.19avg. 13F price*

At the end of Q1 2026, 12 institutions reported holding Aethlon Med Inc. in their 13F filings, up 4 from Q4 2025. 6 opened new positions and 2 sold out. The largest holders were Geode Capital Management, LLC ($53K), Ikarian Capital, LLC ($31K) and Shay Capital LLC ($31K).

Company
Aethlon Med Inc.
CUSIP
00808Y604
Latest filing quarter
Q2 2026

History

Number of 13F holders

05101520 Q3 2025: 1Q3 2025Q4 2025: 8Q4 2025Q1 2026: 12Q1 2026Q2 2026: 17Q2 2026

Total Exit/New Position Q4 2025 → Q1 2026

InstitutionsTotal Value
New Positions6$119K
Exits2$108

All 13F filers, Q4 2025 → Q1 2026: 54,344 shares bought and 39 shares sold, net +54,305 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 12 holders

Geode Capital Management, LLC 0.00% New 24,364 $53K
Ikarian Capital, LLC 0.00% No change 14,364 $31K
Shay Capital LLC 0.00% New 14,124 $31K
XTX Topco Ltd 0.00% New 13,342 $29K
Morgan Stanley 0.00% No change 2,047 $4K
Tower Research Capital LLC (TRC) 0.00% New 1,611 $4K
UBS Group AG 0.00% New 895 $2K
Group One Trading LLC 0.00% No change 14 $31
BlackRock, Inc. 0.00% No change 10 $22
Caitong International Asset Management Co., Ltd 0.00% New 8 $18
Wells Fargo & Company 0.00% No change 3 $6
Danske Bank A/S 0.00% No change 1 $2

"% of holder's portfolio" is AETHLON MED INC's weight in each manager's 13F, not the share of Aethlon Med Inc. the manager owns.